Literature DB >> 11943426

Changes in the pool of bile acids in hepatocyte nuclei during rat liver regeneration.

Maria J Monte1, Maria C Martinez-Diez, Mohamad Y El-Mir, Maria E Mendoza, Pilar Bravo, Oriol Bachs, Jose J G Marin.   

Abstract

BACKGROUND/AIMS: To investigate changes in nuclear bile acids (BAs) during rat liver regeneration.
METHODS: Nuclei were isolated from control rat livers and after two-thirds partial hepatectomy (PH). BAs in bile, liver homogenate and nuclei were measured by gas chromatography-mass spectrometry. Nuclear translocation of radiolabeled BAs was determined using fresh isolated hepatocytes from control donors.
RESULTS: Liver BA concentrations were transiently reduced after PH. Relative increases in: -MCA at 1 day, deoxycholic acid at 7 days and cholic acid (CA) at 3 and 14 days were found. Nuclear BAs accounted for <0.5% of liver BAs. Contamination with cytosolic BAs during nuclei isolation was <4%. Unconjugated- and conjugated-CA were able to reach the nucleus with similar efficiency. The pattern of nuclear BAs--CA (80%) and ursodeoxycholic acid (UDCA) (8.5%) being the most abundant--did not match that found in liver or bile. A transient decrease in CA/UDCA ratio, in absence of significant change in total BA content, was observed in nuclei after PH. "Flat" BA species were only detected in homogenate, but not in nuclei, at 1 day after PH.
CONCLUSIONS: BA pool in nuclei of rat hepatocytes, whose composition is different to that of total liver BA pool, undergoes important changes during liver regeneration.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11943426     DOI: 10.1016/s0168-8278(01)00296-3

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  7 in total

1.  Quantification of common and planar bile acids in tissues and cultured cells.

Authors:  Stephanie J Shiffka; Jace W Jones; Linhao Li; Ann M Farese; Thomas J MacVittie; Hongbing Wang; Peter W Swaan; Maureen A Kane
Journal:  J Lipid Res       Date:  2020-07-22       Impact factor: 5.922

2.  Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.

Authors:  Patricia Munoz-Garrido; José J G Marin; María J Perugorria; Aura D Urribarri; Oihane Erice; Elena Sáez; Miriam Úriz; Sarai Sarvide; Ainhoa Portu; Axel R Concepcion; Marta R Romero; María J Monte; Álvaro Santos-Laso; Elizabeth Hijona; Raúl Jimenez-Agüero; Marco Marzioni; Ulrich Beuers; Tatyana V Masyuk; Nicholas F LaRusso; Jesús Prieto; Luis Bujanda; Joost P H Drenth; Jesús M Banales
Journal:  J Hepatol       Date:  2015-06-01       Impact factor: 25.083

3.  Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated method.

Authors:  Juan C García-Cañaveras; M Teresa Donato; José V Castell; Agustín Lahoz
Journal:  J Lipid Res       Date:  2012-07-19       Impact factor: 5.922

Review 4.  Bile acids: regulation of apoptosis by ursodeoxycholic acid.

Authors:  Joana D Amaral; Ricardo J S Viana; Rita M Ramalho; Clifford J Steer; Cecília M P Rodrigues
Journal:  J Lipid Res       Date:  2009-05-05       Impact factor: 5.922

5.  Post-hepatectomy liver regeneration in the context of bile acid homeostasis and the gut-liver signaling axis.

Authors:  Lianne de Haan; Sarah J van der Lely; Anne-Loes K Warps; Quincy Hofsink; Pim B Olthof; Mark J de Keijzer; Daniël A Lionarons; Lionel Mendes-Dias; Bote G Bruinsma; Korkut Uygun; Hartmut Jaeschke; Geoffrey C Farrell; Narci Teoh; Rowan F van Golen; Tiangang Li; Michal Heger
Journal:  J Clin Transl Res       Date:  2018-02-16

6.  The Effects of Ursodeoxycholic Acid Pretreatment in an Experimental Setting of Extended Hepatectomy: A Feasibility Study.

Authors:  Anna Paspala; Dimitrios Papakonstantinou; Anastasia Prodromidou; Nick Danias; Anastasios Machairas; Georgios Agrogiannis; Nikolaos Machairas; Nikolaos J Zavras; Paulos Patapis; Emmanouil Pikoulis
Journal:  Cureus       Date:  2020-12-17

7.  The Role of Farnesoid X Receptor in Accelerated Liver Regeneration in Rats Subjected to ALPPS.

Authors:  Noemi Daradics; Pim B Olthof; Andras Budai; Michal Heger; Thomas M van Gulik; Andras Fulop; Attila Szijarto
Journal:  Curr Oncol       Date:  2021-12-09       Impact factor: 3.677

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.